Crossmark

Development and Validation of RP-UHPLC Method for Quantification of Gliclazide in Bulk and Pharmaceutical Dosage Form Using Quality-by-Design (QbD) Approach: A Shifting Paradigm

Crossref DOI link: https://doi.org/10.1007/s10337-022-04175-7

Published Online: 2022-06-22

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bordoloi, Ripunjoy https://orcid.org/0000-0002-2043-6915
Ahmed, Abdul Baquee

Baishya, Himakshi
License Information

Text and Data Mining valid from 2022-06-22

Version of Record valid from 2022-06-22
More Information

Article History

Received: 7 March 2022

Revised: 20 May 2022

Accepted: 28 May 2022

First Online: 22 June 2022

Declarations

:

: The authors declare that they have no conflict of interests.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below